AU:NUZ Stock Latest News
Company AnnouncementsNeurizon Therapeutics Halts Trading Ahead of Capital Raising Outcome3d ago
Company AnnouncementsNeurizon Advances NUZ-001 ALS Program With Full Trial Enrolment and Strengthened Funding4d ago
Company AnnouncementsNeurizon Therapeutics Sets Hybrid AGM, Moves to Digital-First Shareholder Communications6d ago
Company AnnouncementsNeurizon Resets 2026 AGM Date and Promotes Investor Engagement1w ago
Company AnnouncementsNeurizon Therapeutics Trims Future Dilution as Options and Rights Lapse2w ago
Company AnnouncementsNeurizon updates investors on NUZ-001 strategy and plans ALS trial milestones3w agoCompany AnnouncementsFDA Feedback Positions Neurizon’s ALS Trial as Potentially Registrational3w ago
Company AnnouncementsNeurizon Therapeutics Redeems 1 Million Convertible Notes Without Conversion1M ago
Company AnnouncementsNeurizon Cuts Convertible Notes and Locks In Standstill as HEALEY ALS Trial Funding Secured1M ago
Company AnnouncementsNeurizon Therapeutics Seeks ASX Quotation for 7.4 Million New Shares1M ago
Company AnnouncementsNIH Backs Neurizon’s NUZ-001 ALS Access Program With Multimillion-Dollar Grant1M ago
Company AnnouncementsNeurizon names seasoned pharma executive Chris Bremer as CEO ahead of key ALS trial readout1M ago
Company AnnouncementsNeurizon Therapeutics Narrows Loss and Strengthens Balance Sheet in 20262M ago
Company AnnouncementsNeurizon Therapeutics Issues Large Tranche of Unquoted Incentive Securities2M ago- Company AnnouncementsNeurizon strengthens Elanco alliance with appointment of new Board observer2M ago
Company AnnouncementsNeurizon accelerates ALS trial and secures supply deal as funding base strengthens3M ago
Company AnnouncementsNeurizon Secures $17.5m Non-Dilutive R&D Financing to Fund ALS Trial3M agoCompany AnnouncementsNeurizon to Outline ALS Trial Progress and NUZ-001 Strategy at Melbourne Investor Briefing3M ago
